Lanean...
Genetic screening for neovascular AMD: cost effective…not so quick
The following is a response to Brown and colleagues (Int J Retin Vitr 1:19, 2015), who analyzed the cost effectiveness of genetic screening for neovascular AMD in Category 3 (intermediate). As explained in this letter, it is premature to propose that genetic screening is cost effective in this setti...
Gorde:
| Argitaratua izan da: | Int J Retina Vitreous |
|---|---|
| Egile nagusia: | |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
BioMed Central
2015
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5088460/ https://ncbi.nlm.nih.gov/pubmed/27847617 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40942-015-0024-5 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|